David Michael Johnson, Director at Zentalis Pharmaceuticals, Inc. (ZNTL), bought 4,000 shares at $18.00 ($72K) on 2020-04-07, disclosed to the SEC on 2020-12-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| AURA | BUY | 2023-11-09 | $1.1M | — | Filing → |
| AURA | BUY | 2023-10-05 | $225K | — | Filing → |
| AURA | BUY | 2023-01-09 | $21K | — | Filing → |